Indication

Impetigo

Impetigo is a highly contagious, superficial bacterial skin infection affecting the epidermis, most frequently observed in children aged two to five years. Read more about Impetigo

49 drugs 43 manufacturers

Advertisement

Drugs that treat it

Common Impetigo therapies.

Showing 10–18 of 49 drugs

MUPIROCIN

TOPICAL ANTIBIOTICS·IMPETIGO
GLENMARK PHARMA

MUPIROCIN

TOPICAL ANTIBIOTICS·IMPETIGO
TEVA USA

MUPIROCIN

TOPICAL ANTIBIOTICS·IMPETIGO
TARO PHARM USA
Filter & compare in the drug finder →Opens the drug finder with Impetigo preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Impetigo.

Impetigo is a highly contagious, superficial bacterial skin infection affecting the epidermis, most frequently observed in children aged two to five years.

It is primarily caused by *Staphylococcus aureus*, *Streptococcus pyogenes* (group A beta-hemolytic streptococcus), or a combination of both pathogens invading intact or compromised skin.

Clinically, the condition manifests as either nonbullous impetigo—distinguished by vesicles or pustules that rupture to yield characteristic honey-colored crusted erosions typically on the face and extremities—or bullous impetigo, which features fragile, fluid-filled flaccid bullae mediated by staphylococcal exfoliative toxins.

Personalize your experience

Follow Impetigo and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it